188 related articles for article (PubMed ID: 25531390)
1. Increased cycling cell numbers and stem cell associated proteins as potential biomarkers for high grade human papillomavirus+ve pre-neoplastic cervical disease.
Canham M; Charsou C; Stewart J; Moncur S; Hoodless L; Bhatia R; Cong D; Cubie H; Busby-Earle C; Williams A; McLoughlin V; Campbell JD; Cuschieri K; Howie S
PLoS One; 2014; 9(12):e115379. PubMed ID: 25531390
[TBL] [Abstract][Full Text] [Related]
2. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
4. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
6. Management and triage of women with human papillomavirus infection in follow-up for low-grade cervical disease: association of HPV-DNA and RNA-based methods.
Rosini S; Zappacosta R; Di Bonaventura G; Caraceni D; Pilla D; Di Girolamo G; Esposito A; Orsini T; Setta S; Vizzino M; Piccolomini M; Piccolomini R
Int J Immunopathol Pharmacol; 2007; 20(2):341-7. PubMed ID: 17624246
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
Peeters E; Wentzensen N; Bergeron C; Arbyn M
Cancer Cytopathol; 2019 Mar; 127(3):169-180. PubMed ID: 30811902
[TBL] [Abstract][Full Text] [Related]
8. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
[TBL] [Abstract][Full Text] [Related]
9. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
10. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
11. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous evolution of human papillomavirus infection in the uterine cervix.
Paraskevaidis E; Kalantaridou SN; Georgiou I; Koliopoulos G; Pappa L; Malamou-Mitsi V; Agnantis NJ; Kitchener HC; Lolis DE
Anticancer Res; 1999; 19(4C):3473-8. PubMed ID: 10629638
[TBL] [Abstract][Full Text] [Related]
13. [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].
Luo GP; Zeng X; Cao HY; Tang D; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):516-522. PubMed ID: 34018374
[TBL] [Abstract][Full Text] [Related]
14. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
15. The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.
Varga N; Mózes J; Keegan H; White C; Kelly L; Pilkington L; Benczik M; Zsuzsanna S; Sobel G; Koiss R; Babarczi E; Nyíri M; Kovács L; Attila S; Kaltenecker B; Géresi A; Kocsis A; O'Leary J; Martin CM; Jeney C
Pathol Oncol Res; 2017 Apr; 23(2):295-305. PubMed ID: 27497597
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
Kottaridi C; Kyrgiou M; Pouliakis A; Magkana M; Aga E; Spathis A; Mitra A; Makris G; Chrelias C; Mpakou V; Paraskevaidis E; Panayiotides JG; Karakitsos P
J Infect Dis; 2017 Mar; 215(5):764-771. PubMed ID: 28170039
[TBL] [Abstract][Full Text] [Related]
17. Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease.
Chambers G; Millan D; Cuschieri K; Cubie HA; Graham SV
J Med Virol; 2014 Apr; 86(4):627-33. PubMed ID: 24142394
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples.
Stevenson A; Kavanagh K; Pan J; Stevenson L; Griffin H; Doorbar J; Scott E; Deeny M; Cuschieri K; Graham SV
J Clin Virol; 2018 Nov; 108():19-25. PubMed ID: 30218891
[TBL] [Abstract][Full Text] [Related]
19. Amplification and overexpression of TP63 and MYC as biomarkers for transition of cervical intraepithelial neoplasia to cervical cancer.
Zhu D; Jiang XH; Jiang YH; Ding WC; Zhang CL; Shen H; Wang XL; Ma D; Hu Z; Wang H
Int J Gynecol Cancer; 2014 May; 24(4):643-8. PubMed ID: 24662128
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
